• tags:Glance Videos
Barti introduces AI transcription tech for optometrists
Products

Barti introduces AI transcription tech for optometrists

New feature to the software company’s OD-only electronic health records platform enables hands-free charting.
Rinsada's irrigating eyelid retractor targets ocular surface restoration
Products

Rinsada's irrigating eyelid retractor targets ocular surface restoration

Inventor Srini Kondapealli, MD, explains how the medical device is a unique game changer for dry eye and allergic conjunctivitis patients.
Keratoconus eye drop regenerates lost collagen in the eye
Research

Keratoconus eye drop regenerates lost collagen in the eye

TheiaNova’s world-first therapy of its kind is featured during ASCRS’s Winning Pitch Challenge as part of the Eyecelerator conference.
Eye safety tips you need to know ahead of the solar eclipse
Events

Eye safety tips you need to know ahead of the solar eclipse

Leading eyecare organizations and clinical experts offer their professional advice for safely watching this year’s big event on April 8.
The Vision Council reports US consumers' prescription purchase choices
Research

The Vision Council reports US consumers' prescription purchase choices

At Vision Expo East, recent findings reveal key insights into online vs in-person buying trends, including which format has higher overall satisfaction rates.
New Contact Lens Institute research reveals untapped contact lens demand
Research

New Contact Lens Institute research reveals untapped contact lens demand

Latest findings previewed at Vision Expo East detail the negative culture surrounding lens wear and how ECPs can influence patient interest.
Here’s why you shouldn’t miss EOE’s first-ever in-person meeting
Events

Here’s why you shouldn’t miss EOE’s first-ever in-person meeting

Kicking off April 19 and 20, the two-day Las Vegas event features on-site and virtual attendance options.
FDA approves clobetasol propionate suspension for postop inflammation and pain
Products

FDA approves clobetasol propionate suspension for postop inflammation and pain

Developed by Formosa with exclusive U.S rights owned by Eyenovia, the novel ophthalmic APP13007 is expected to launch mid-2024.
Nanodropper's eyedrop adaptor is heading to space
Products

Nanodropper's eyedrop adaptor is heading to space

Company's flagship product is scheduled to launch on March 2, with plans to undergo microgravity testing.
Foundation Fighting Blindness to host IRD best practices webinar
Events

Foundation Fighting Blindness to host IRD best practices webinar

Virtual session hosted by two leading experts seeks to educate on how best to manage and care for this patient base.
FDA approves Bausch+ Lomb’s TENEO excimer laser platform
Products

FDA approves Bausch+ Lomb’s TENEO excimer laser platform

Now considered the smallest excimer laser by footprint in the U.S., it’s designed for LASIK surgery in patients with myopia and myopic astigmatism.
Azura releases positive data from phase 2 trial of AZR-MD-001 for contact lens discomfort
Pipeline

Azura releases positive data from phase 2 trial of AZR-MD-001 for contact lens discomfort

Latest results on topical ointment support prior phase 2 findings unveiled at AAOPT.
Luminopia ranks among best inventions of 2023
Products

Luminopia ranks among best inventions of 2023

The binocular digital platform is the first therapy for treating visual acuity in pediatric amblyopia patients.
EyeCorps nonprofit seeks to end preventable blindness in Africa
Research

EyeCorps nonprofit seeks to end preventable blindness in Africa

Co-founder Susan MacDonald, MD, discusses addressing the gaps in eyecare and an upcoming trip to educate and train ophthalmology professionals.
Personalized occlusion medical device targets DED treatment
Products

Personalized occlusion medical device targets DED treatment

AesculaTech’s Humidifeye is featured during AAO 2023’s The Winning Pitch Challenge. 
Positive 24-month data released for phase 3 trials on Syfovre
Products

Positive 24-month data released for phase 3 trials on Syfovre

Latest data supports the FDA-approved therapeutic for treating GA.
Bausch + Lomb launches enVista Aspire IOL in the US
Products

Bausch + Lomb launches enVista Aspire IOL in the US

New IOL addition to the enVista family treats lower levels of astigmatism with optimized extended range of vision.
FDA approves Orasis's QLOSI for presbyopia
Products

FDA approves Orasis's QLOSI for presbyopia

The preservative-free, low-dose eye drop will be commercially available in 2024.
Managing ocular emergencies as an on-call optometrist
Research

Managing ocular emergencies as an on-call optometrist

Jessilin Quint, OD, MS, FAAO, offers clinicians a sneak peek of her Vision Expo West presentation.
What to rule out before diagnosing DED
Research

What to rule out before diagnosing DED

Mile Brujic, OD, FAAO, offers clinicians a sneak peek of his Vision Expo West presentation.